The legislation introduces several significant modifications to existing state laws surrounding dietary supplements and consumer protection. Under this act, kratom retailers are prohibited from selling kratom to individuals under the age of 21, and they must ensure that products are safe for consumption. The penalties for non-compliance include civil fines for first and second offenses, escalating to potential criminal charges for serious violations, such as selling adulterated or contaminated products. The implementation of this law is expected to impact how kratom products are marketed and sold across the state, with a focus on ensuring public health and safety.
Summary
Assembly Bill A4222, known as the New Jersey Kratom Consumer Protection Act, aims to regulate the sale and distribution of kratom products within New Jersey. The bill seeks to ensure consumer safety by establishing stringent requirements for product labeling, including accurate disclosures regarding the alkaloid content of kratom. It thoroughly defines kratom, labeling requirements, and the responsibilities of kratom retailers. Furthermore, it mandates that the Department of Health oversee the regulation, setting safety standards for kratom consumption and methods of product registration.
Contention
Notably, discussions surrounding this bill may revolve around the balance between consumer protection and business regulation. Some stakeholders argue that the legislation could hinder the availability of kratom products for adult consumers who advocate for its use. Critics may emphasize concerns regarding over-regulation, suggesting it could limit access to legal alternatives to manage pain or other health issues. Advocates for the bill stress the need for health safety standards and consumer awareness, highlighting that a regulated market may help dispel misinformation surrounding kratom and improve product quality.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25
Criminal procedure: sentencing guidelines; sentencing guidelines for manufacturing, creating, delivering, or possessing with intent certain schedule 1 and 2 controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 460'25
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25